134 related articles for article (PubMed ID: 19649988)
1. Strategies for the episomal modification of cells.
Wong SP; Argyros O; Coutelle C; Harbottle RP
Curr Opin Mol Ther; 2009 Aug; 11(4):433-41. PubMed ID: 19649988
[TBL] [Abstract][Full Text] [Related]
2. Non-viral episomal modification of cells using S/MAR elements.
Argyros O; Wong SP; Harbottle RP
Expert Opin Biol Ther; 2011 Sep; 11(9):1177-91. PubMed ID: 21548848
[TBL] [Abstract][Full Text] [Related]
3. Generation of a tumor- and tissue-specific episomal non-viral vector system.
Haase R; Magnusson T; Su B; Kopp F; Wagner E; Lipps H; Baiker A; Ogris M
BMC Biotechnol; 2013 Jun; 13():49. PubMed ID: 23734827
[TBL] [Abstract][Full Text] [Related]
4. Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage.
Wong SP; Argyros O; Coutelle C; Harbottle RP
Gene Ther; 2011 Jan; 18(1):82-7. PubMed ID: 20739959
[TBL] [Abstract][Full Text] [Related]
5. Enhancing expression level and stability of transgene mediated by episomal vector via buffering DNA methyltransferase in transfected CHO cells.
Wang XY; Yi DD; Wang TY; Wu YF; Chai YR; Xu DH; Zhao CP; Song C
J Cell Biochem; 2019 Sep; 120(9):15661-15670. PubMed ID: 31074065
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy progress and prospects: episomally maintained self-replicating systems.
Conese M; Auriche C; Ascenzioni F
Gene Ther; 2004 Dec; 11(24):1735-41. PubMed ID: 15385951
[TBL] [Abstract][Full Text] [Related]
7. Physiological levels of HBB transgene expression from S/MAR element-based replicating episomal vectors.
Sgourou A; Routledge S; Spathas D; Athanassiadou A; Antoniou MN
J Biotechnol; 2009 Aug; 143(2):85-94. PubMed ID: 19559736
[TBL] [Abstract][Full Text] [Related]
8. Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy.
Mulia GE; Picanço-Castro V; Stavrou EF; Athanassiadou A; Figueiredo ML
Hum Gene Ther; 2021 Oct; 32(19-20):1076-1095. PubMed ID: 34348480
[TBL] [Abstract][Full Text] [Related]
9. Genetic modification of cancer cells using non-viral, episomal S/MAR vectors for in vivo tumour modelling.
Argyros O; Wong SP; Gowers K; Harbottle RP
PLoS One; 2012; 7(10):e47920. PubMed ID: 23110132
[TBL] [Abstract][Full Text] [Related]
10. Modified S/MAR episomal vectors for stably expressing fluorescent protein-tagged transgenes with small cell-to-cell fluctuations.
Mizutani A; Kikkawa E; Matsuno A; Shigenari A; Okinaga H; Murakami M; Ishida H; Tanaka M; Inoko H
Anal Biochem; 2013 Dec; 443(1):113-6. PubMed ID: 23969013
[TBL] [Abstract][Full Text] [Related]
11. MAR characteristic motifs mediate episomal vector in CHO cells.
Lin Y; Li Z; Wang T; Wang X; Wang L; Dong W; Jing C; Yang X
Gene; 2015 Apr; 559(2):137-43. PubMed ID: 25598284
[TBL] [Abstract][Full Text] [Related]
12. Shortened nuclear matrix attachment regions are sufficient for replication and maintenance of episomes in mammalian cells.
Wang XY; Zhang X; Wang TY; Jia YL; Xu DH; Yi DD
Mol Biol Cell; 2019 Oct; 30(22):2761-2770. PubMed ID: 31509492
[TBL] [Abstract][Full Text] [Related]
13. Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.
Argyros O; Wong SP; Niceta M; Waddington SN; Howe SJ; Coutelle C; Miller AD; Harbottle RP
Gene Ther; 2008 Dec; 15(24):1593-605. PubMed ID: 18633447
[TBL] [Abstract][Full Text] [Related]
14. An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency.
Lufino MM; Manservigi R; Wade-Martins R
Nucleic Acids Res; 2007; 35(15):e98. PubMed ID: 17675302
[TBL] [Abstract][Full Text] [Related]
15. Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells.
Xu Z; Chen F; Zhang L; Lu J; Xu P; Liu G; Xie X; Mu W; Wang Y; Liu D
Sci China Life Sci; 2016 Oct; 59(10):1024-1033. PubMed ID: 27614752
[TBL] [Abstract][Full Text] [Related]
16. Cell Compatibility of an Eposimal Vector Mediated by the Characteristic Motifs of Matrix Attachment Regions.
Wang TY; Wang L; Yang YX; Zhao CP; Jia YL; Li Q; Zhang JH; Peng YY; Wang M; Xu HY; Wang XY
Curr Gene Ther; 2016; 16(4):271-277. PubMed ID: 27915978
[TBL] [Abstract][Full Text] [Related]
17. Scaffold/matrix attached region-based nonviral episomal vectors.
Hagedorn C; Wong SP; Harbottle R; Lipps HJ
Hum Gene Ther; 2011 Aug; 22(8):915-23. PubMed ID: 21644838
[TBL] [Abstract][Full Text] [Related]
18. Long-term episomal transgene expression from mitotically stable integration-deficient lentiviral vectors.
Kymäläinen H; Appelt JU; Giordano FA; Davies AF; Ogilvie CM; Ahmed SG; Laufs S; Schmidt M; Bode J; Yáñez-Muñoz RJ; Dickson G
Hum Gene Ther; 2014 May; 25(5):428-42. PubMed ID: 24483952
[TBL] [Abstract][Full Text] [Related]
19. Developing extrachromosomal gene expression vector technologies: an overview.
Wade-Martins R
Methods Mol Biol; 2011; 738():1-17. PubMed ID: 21431716
[TBL] [Abstract][Full Text] [Related]
20. The functional role of S/MARs in episomal vectors as defined by the stress-induced destabilization profile of the vector sequences.
Giannakopoulos A; Stavrou EF; Zarkadis I; Zoumbos N; Thrasher AJ; Athanassiadou A
J Mol Biol; 2009 Apr; 387(5):1239-49. PubMed ID: 19248788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
